LYYB:F:F-Multi Units France - Lyxor MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 510.1

Change

+1.10 (+0.22)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.35 (+1.32%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 112.00B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.86 (+0.15%)

USD 98.90B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.70 (+1.29%)

USD 92.14B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.35B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.19 (+1.28%)

USD 53.27B
VUSA:F Vanguard Funds Public Limited ..

+0.31 (+0.30%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.38 (+0.37%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.14%)

USD 40.47B
0ZC:F Zscaler Inc

+2.84 (+1.65%)

USD 37.92B

ETFs Containing LYYB:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.99% 87% B+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.99% 87% B+ 77% C+
Trailing 12 Months  
Capital Gain 36.52% 84% B 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.52% 84% B 75% C
Trailing 5 Years  
Capital Gain 96.48% 94% A 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 96.48% 94% A 83% B
Average Annual (5 Year Horizon)  
Capital Gain 14.40% 87% B+ 76% C+
Dividend Return 14.40% 85% B 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.40% 38% F 76% C+
Risk Adjusted Return 93.51% 93% A 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.